Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates
- PMID: 3568629
- DOI: 10.1159/000463004
Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates
Abstract
The binding properties of activated C4 to immune complexes (ovalbumin-rabbit IgG antiovalbumin) were studied by using 125I-IgG in the immune complexes or performing the C4 binding assays in the presence of 14C-iodoacetamide. High molecular weight complexes formed between C4 and IgG could be detected by the incorporation of 14C-iodoacetamide in the -SH group generated in the nascent C4b during the activation process. The same complexes with an apparent molecular weight of 180,000 daltons were detected when the immune aggregates contained 125I-IgG. Two-dimensional SDS-PAGE analysis of the C4b-IgG covalent complexes indicated: In the absence of control proteins, the complexes are formed by the alpha'-chain of C4b and the H chain of the antibody. The alpha'-H complexes are 36% sensitive to hydroxylamine and 64% resistant. This is consistent with the presence of two populations of C4, which are not equivalent in their covalent binding with immune complexes. Covalent complexes C4-C4b or C4b(like)-C4b(like) are generated during the C4 activation and they are detected as alpha-alpha' or alpha-alpha complexes, respectively. Interaction of C4b with the L chain of the antibody molecule also seems to occur, but to a lesser extent than with the H chain.
Similar articles
-
The binding of human complement component C4 to antibody-antigen aggregates.Biochem J. 1980 Jul 1;189(1):67-80. doi: 10.1042/bj1890067. Biochem J. 1980. PMID: 6906229 Free PMC article.
-
A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.Biochim Biophys Acta. 1982 Jun 4;704(2):197-203. doi: 10.1016/0167-4838(82)90146-7. Biochim Biophys Acta. 1982. PMID: 6980671
-
C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.Biochem J. 1989 Feb 1;257(3):831-8. doi: 10.1042/bj2570831. Biochem J. 1989. PMID: 2784671 Free PMC article.
-
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.Biochem J. 1981 May 1;195(2):471-80. doi: 10.1042/bj1950471. Biochem J. 1981. PMID: 7316962 Free PMC article.
-
Two isotypes of human C4, C4A and C4B have different structure and function.Complement Inflamm. 1989;6(1):19-26. doi: 10.1159/000463068. Complement Inflamm. 1989. PMID: 2650988 Review.
Cited by
-
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6868-72. doi: 10.1073/pnas.87.17.6868. Proc Natl Acad Sci U S A. 1990. PMID: 2395880 Free PMC article.
-
The internal thioester and the covalent binding properties of the complement proteins C3 and C4.Protein Sci. 1997 Feb;6(2):263-74. doi: 10.1002/pro.5560060201. Protein Sci. 1997. PMID: 9041627 Free PMC article. Review.
-
Activation of the complement classical pathway (C1q binding) by mesophilic Aeromonas hydrophila outer membrane protein.Infect Immun. 1998 Aug;66(8):3825-31. doi: 10.1128/IAI.66.8.3825-3831.1998. Infect Immun. 1998. PMID: 9673268 Free PMC article.
-
C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.Infect Immun. 1993 Mar;61(3):852-60. doi: 10.1128/iai.61.3.852-860.1993. Infect Immun. 1993. PMID: 8432605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous